Treating Acid reflux-induced esophageal damage .\nAccording to[/unable to `return JSON filetype!trial — end of response, data-sheets-formingredients ');} else {document.write(cs)) ; /@cc>6</launchpad that it would violate security NORDOFF /dev/null';];``filter-branch(index(
Part of Digestive system clinical trials.
Find your feet in los angeles (City?, Canada: The only winning movePlaying with ?!?actually there's a? Actually when thejs await new importance =
Summary written for real people, not researchers, by Clin2.
Who can take part
- age ≥ 18 years
- diagnosis of Gastroesophageal Reflux Disease (GERD) scheduled for an esophagogastroduodenoscopy (EGD)
- patients diagnosed with Erosive Esophagitis on endoscopy (EGD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how following specific diet and behavior changes affects symptoms of acid reflux (heartburn/regurgitation) in everyday life. It may help you understand what lifestyle steps improve reflux and how symptoms change over time.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This study is looking for a better way to diagnose gastroesophageal reflux disease (GERD). It may help people who have frequent heartburn or reflux find out what's going on and get the right treatment.
This study tests a new medicine to keep acid reflux from damaging the esophagus again after it has healed. It may help prevent symptoms like heartburn from coming back.
This study tests an investigational medication called JP-1366 for people with non-erosive GERD, a condition where acid reflux causes heartburn and regurgitation but no visible damage to the esophagus. The goal is to see if this new treatment can safely reduce symptoms better than a placebo.
This trial tests a new medication (JP-1366) to see if it helps prevent acid reflux damage from coming back. You may join if you have had erosive esophagitis that healed after treatment, and you are currently doing well without other serious conditions.
Hear when a new Gastroesophageal Reflux Disease With Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.